A Neuroimaging Approach to Advance Mechanistic Understanding of Tobacco Use Escalation Risk Among Young Adult African American Vapers
1 other identifier
interventional
24
1 country
1
Brief Summary
60 young adult African American vapers who are not current smokers will participate in a baseline functional magnetic resonance imaging (fMRI) experiment, with 4 weekly follow-up surveys to gauge their tobacco use behaviors following the baseline scan. Baseline fMRI tasks will probe critical neurocognitive markers with high potential to account for individual differences in nicotine use prognosis and responsiveness to anti-vaping public service announcements (PSAs).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2023
CompletedFirst Posted
Study publicly available on registry
April 26, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedSeptember 23, 2025
September 1, 2025
2.1 years
April 13, 2023
September 18, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Self-report smoking severity in the following month
The weekly number of cigarettes smoked will be assessed with the timeline follow-back measures. Specifically, participants will be asked to retrospectively estimate their daily cigarette use for the 7 days prior to the weekly survey date. The four weekly estimates will be averaged to create the monthly smoking severity measure. The greater the number, the higher the smoking severity in that month.
1 month
Self-report vaping severity in the following month
The weekly number of vaping sessions (a vaping session refers to a minimum of about 15 puffs or vaping that lasts around 10 minutes) will be assessed with the timeline follow-back measures. Specifically, participants will be asked to retrospectively estimate their daily vaping sessions for the 7 days prior to the weekly survey date. The four weekly estimates will be averaged to create the monthly vaping severity measure. The greater the number, the higher the vaping severity in that month.
1 month
Self-report vaping intention
Right after the fMRI scan and the anti-vaping PSA exposure, participants will be asked to indciate their intention to use e-cigarette in the next week.
1 week
Secondary Outcomes (3)
Message effectiveness perceptions
1 week
Self-report other tobacco use severity in the following month
1 month
Self-report other substance use severity in the following month
1 month
Study Arms (1)
Message exposure
EXPERIMENTALParticipants will all be exposed to anti-vaping PSAs utilizing cognitive, emotional, and social appeals, aiming to persuade them to reduce or quit using e-cigarettes.
Interventions
Exposing African American young adult vapers to persuasive anti-vaping public service announcements (PSAs) with the goal of reducing their subsequent e-cigarette use.
Eligibility Criteria
You may qualify if:
- years old
- used e-cigarettes or other vaping devices at least once during the past 30 days
- did not smoke or use cigarettes during the past 30 days
- self-identify as African American
- magnetic resonance imaging (MRI) compatible and safe
You may not qualify if:
- younger than 18 years old, or older than 29 years old
- did not use e-cigarettes or other vaping devices during the past 30 days
- smoked or use cigarettes at least once during the past 30 days
- history of a major neurological, psychiatric, or medical disorder
- MRI contraindications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UGA Bio-imaging Research Center
Athens, Georgia, 30602, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- The participants will be prevented from knowing the different message appeals to which they are exposed.
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 13, 2023
First Posted
April 26, 2023
Study Start
May 1, 2023
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
September 23, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
The proposed research is under the 500k threshold for required resource sharing. The PI and research team are committed to resource sharing; however, in the context of the proposed study, no plans are in place to make data available outside of the research team.